139 related articles for article (PubMed ID: 15997604)
21. Cost-effectiveness of a program to prevent depression relapse in primary care.
Simon GE; Von Korff M; Ludman EJ; Katon WJ; Rutter C; Unützer J; Lin EH; Bush T; Walker E
Med Care; 2002 Oct; 40(10):941-50. PubMed ID: 12395027
[TBL] [Abstract][Full Text] [Related]
22. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
Leelahanaj T
J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of improving primary care treatment of late-life depression.
Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
[TBL] [Abstract][Full Text] [Related]
25. Counseling versus antidepressant therapy for the treatment of mild to moderate depression in primary care: economic analysis.
Miller P; Chilvers C; Dewey M; Fielding K; Gretton V; Palmer B; Weller D; Churchill R; Williams I; Bedi N; Duggan C; Lee A; Harrison G
Int J Technol Assess Health Care; 2003; 19(1):80-90. PubMed ID: 12701941
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial.
Asarnow JR; Jaycox LH; Duan N; LaBorde AP; Rea MM; Murray P; Anderson M; Landon C; Tang L; Wells KB
JAMA; 2005 Jan; 293(3):311-9. PubMed ID: 15657324
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of a primary care treatment program for depression in low-income women in Santiago, Chile.
Araya R; Flynn T; Rojas G; Fritsch R; Simon G
Am J Psychiatry; 2006 Aug; 163(8):1379-87. PubMed ID: 16877650
[TBL] [Abstract][Full Text] [Related]
28. The health value and cost of care for major depression.
Watkins KE; Burnam MA; Orlando M; Escarce JJ; Huskamp HA; Goldman HH
Value Health; 2009; 12(1):65-72. PubMed ID: 19911440
[TBL] [Abstract][Full Text] [Related]
29. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(6):1-51. PubMed ID: 27110317
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression.
Simon GE; Katon WJ; VonKorff M; Unützer J; Lin EH; Walker EA; Bush T; Rutter C; Ludman E
Am J Psychiatry; 2001 Oct; 158(10):1638-44. PubMed ID: 11578996
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression.
Vos T; Corry J; Haby MM; Carter R; Andrews G
Aust N Z J Psychiatry; 2005 Aug; 39(8):683-92. PubMed ID: 16050922
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of a disease management program for major depression in elderly primary care patients.
Bosmans J; de Bruijne M; van Hout H; van Marwijk H; Beekman A; Bouter L; Stalman W; van Tulder M
J Gen Intern Med; 2006 Oct; 21(10):1020-6. PubMed ID: 16836625
[TBL] [Abstract][Full Text] [Related]
33. Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.
Khoo AL; Zhou HJ; Teng M; Lin L; Zhao YJ; Soh LB; Mok YM; Lim BP; Gwee KP
CNS Drugs; 2015 Aug; 29(8):695-712. PubMed ID: 26293743
[TBL] [Abstract][Full Text] [Related]
34. Incremental Benefit-Cost of MOMCare: Collaborative Care for Perinatal Depression Among Economically Disadvantaged Women.
Grote NK; Simon GE; Russo J; Lohr MJ; Carson K; Katon W
Psychiatr Serv; 2017 Nov; 68(11):1164-1171. PubMed ID: 28669288
[TBL] [Abstract][Full Text] [Related]
35. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
[TBL] [Abstract][Full Text] [Related]
36. Cost-Effectiveness Evaluation of Collaborative Care for Diabetes and Depression in Primary Care.
Johnson JA; Lier DA; Soprovich A; Al Sayah F; Qiu W; Majumdar SR
Am J Prev Med; 2016 Jul; 51(1):e13-20. PubMed ID: 26947212
[TBL] [Abstract][Full Text] [Related]
37. Resolving disparities in antidepressant treatment and quality-of-life outcomes between uninsured and insured primary care patients with depression.
Smith JL; Rost KM; Nutting PA; Elliott CE
Med Care; 2001 Sep; 39(9):910-22. PubMed ID: 11502949
[TBL] [Abstract][Full Text] [Related]
38. Are psychological treatments for depression in primary care cost-effective?
Bosmans JE; van Schaik DJ; de Bruijne MC; van Hout HP; van Marwijk HW; van Tulder MW; Stalman WA
J Ment Health Policy Econ; 2008 Mar; 11(1):3-15. PubMed ID: 18424872
[TBL] [Abstract][Full Text] [Related]
39. Gender patterns in cost effectiveness of quality improvement for depression: results of a randomized, controlled trial.
Schoenbaum M; Sherbourne C; Wells K
J Affect Disord; 2005 Aug; 87(2-3):319-25. PubMed ID: 16005520
[TBL] [Abstract][Full Text] [Related]
40. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
